Seagen (formerly Seattle Genetics) is a biotechnology company focused on developing innovative therapies for the treatment of cancer. The company, headquartered in Bothell, Washington, is the industry leader in antibody-drug conjugates or ADCs, a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. TUKYSA® is indicated for the treatment of adult patients with advanced metastatic HER2-positive breast cancer. While at Alexander Health, I designed print and digital pieces, including banner ads, brochures, and CVAs, for both clinical and consumer audiences.
![](https://cdn.myportfolio.com/0ca1cdf2f7733284d0bbd5e39315e500/2236d84a-5ee2-4e5d-947d-9dfb4759ab9e_rw_1920.jpg?h=3cb3f20d2b329d8e2acf3252a3ca2f71)
![](https://cdn.myportfolio.com/0ca1cdf2f7733284d0bbd5e39315e500/81cdac3a-1c8f-4878-b246-ce5d3a9d6eb0_rw_1920.jpg?h=7ebb22603dcafdade5351ac21c616f32)
![](https://cdn.myportfolio.com/0ca1cdf2f7733284d0bbd5e39315e500/b0cba36d-5fec-4d08-b24f-b48c19165d30_rw_1200.jpg?h=dbd39fc5deb86f6285aca4e4b477c4d2)
![](https://cdn.myportfolio.com/0ca1cdf2f7733284d0bbd5e39315e500/b9e8b186-5628-4d1d-b1fa-e1a75577a080_rw_3840.jpg?h=0bc25b7fa607ad7a4cc5a66ff00427c1)